Announced
Completed
Financials
Tags
Acquisition
Private Equity
United States
pharmaceutical marketing
analytics platform
digital drug information
Digital Services
Single Bidder
Completed
patient support
Private
Friendly
Majority
Synopsis
Genstar Capital, a private equity firm, completed an investment in its portfolio company ConnectiveRx, a provider of technology-enabled biopharmaceutical services. Financial terms were not disclosed. Genstar will continue as majority investor and will be joined by funds managed by Harvest Partners and funds managed by Blackstone Tactical Opportunities as minority investors. The transaction provides ConnectiveRx with enhanced financial flexibility, allowing it to continue its product innovation-driven growth, while also enabling the Company to realize an attractive outcome for its shareholders.
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.